ATE451108T1 - Verfahren zur behandlung von verletzungen des nervensystems in verbindung mit einer blutung - Google Patents

Verfahren zur behandlung von verletzungen des nervensystems in verbindung mit einer blutung

Info

Publication number
ATE451108T1
ATE451108T1 AT03759773T AT03759773T ATE451108T1 AT E451108 T1 ATE451108 T1 AT E451108T1 AT 03759773 T AT03759773 T AT 03759773T AT 03759773 T AT03759773 T AT 03759773T AT E451108 T1 ATE451108 T1 AT E451108T1
Authority
AT
Austria
Prior art keywords
nervous system
hemorrhage
system injuries
injuries associated
treating nervous
Prior art date
Application number
AT03759773T
Other languages
English (en)
Inventor
Clifford Steer
Walter Low
Cecilia Rodriguez
Zhenhong Nan
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Application granted granted Critical
Publication of ATE451108T1 publication Critical patent/ATE451108T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AT03759773T 2002-11-07 2003-10-08 Verfahren zur behandlung von verletzungen des nervensystems in verbindung mit einer blutung ATE451108T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42521002P 2002-11-07 2002-11-07
US45161503P 2003-03-03 2003-03-03
PCT/US2003/031989 WO2004043342A2 (en) 2002-11-07 2003-10-08 Methods of treating injuries of the nervous system associated with hemorrhage

Publications (1)

Publication Number Publication Date
ATE451108T1 true ATE451108T1 (de) 2009-12-15

Family

ID=32314576

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03759773T ATE451108T1 (de) 2002-11-07 2003-10-08 Verfahren zur behandlung von verletzungen des nervensystems in verbindung mit einer blutung

Country Status (9)

Country Link
US (1) US20060135494A1 (de)
EP (1) EP1575578B1 (de)
JP (1) JP2006510740A (de)
KR (1) KR20050103185A (de)
AT (1) ATE451108T1 (de)
AU (1) AU2003275495A1 (de)
DE (1) DE60330501D1 (de)
HK (1) HK1086479A1 (de)
WO (1) WO2004043342A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772220B2 (en) 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US20030044413A1 (en) * 2000-08-15 2003-03-06 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
US20060204481A1 (en) * 2003-04-02 2006-09-14 Steer Clifford J Methods of promoting cell viability
BRPI0514725A (pt) * 2004-08-30 2008-06-24 Seo Hong Yoo efeito neuroprotetor de udca solubilizado no modelo isquêmico focal
EP1809330B1 (de) 2004-10-15 2011-04-27 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
KR20080012258A (ko) * 2005-02-10 2008-02-11 리전츠 오브 더 유니버스티 오브 미네소타 시각장애를 치료하는 방법
CA2679608A1 (en) * 2006-03-22 2007-10-04 President And Fellows Of Harvard College Methods and compositions for treating hypercholesterolemia and atherosclerosis
KR20180029317A (ko) * 2016-09-12 2018-03-21 경상대학교산학협력단 간손상 예방, 개선 또는 치료용 조성물
KR101953298B1 (ko) * 2017-07-18 2019-02-28 의료법인 성광의료재단 우르소데옥시콜산을 함유하는 염증성 질환 또는 척수 손상 예방 또는 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0552373T3 (da) * 1991-07-03 1999-12-27 Otsuka Pharma Co Ltd Apoptoseregulator
US5656725A (en) * 1995-05-12 1997-08-12 Apoptosis Technology, Inc. Peptides and compositions which modulate apoptosis
WO1999015179A1 (en) * 1997-09-25 1999-04-01 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
JP2002504514A (ja) * 1998-02-27 2002-02-12 ニュートラマックス ラボラトリーズ，インコーポレイテッド 肝臓傷害の予防、治療及び修復のためのｌ−エルゴチオネイン、ノゲシ及びｓ−アデノシルメテオニン
GB0019290D0 (en) * 2000-08-04 2000-09-27 Symphar Sa Methods for inducing apolipoprotein E secretion
US20030044413A1 (en) * 2000-08-15 2003-03-06 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells

Also Published As

Publication number Publication date
EP1575578A2 (de) 2005-09-21
AU2003275495A8 (en) 2004-06-03
KR20050103185A (ko) 2005-10-27
EP1575578A4 (de) 2007-10-10
HK1086479A1 (en) 2006-09-22
EP1575578B1 (de) 2009-12-09
WO2004043342A3 (en) 2004-07-15
JP2006510740A (ja) 2006-03-30
DE60330501D1 (de) 2010-01-21
AU2003275495A1 (en) 2004-06-03
WO2004043342A2 (en) 2004-05-27
US20060135494A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
MX2021009622A (es) Metodos para tratar la colestasis.
ATE521357T1 (de) Verfahren zur behandlung von hepatitis
ATE365047T1 (de) N-terminal monopegylierte menschliche wachstumshormon-konjugate, verfahren zu ihrer herstellung und ihre anwendung
DE69941031D1 (de) Zusammensetzungen und verfahren zur erzeugung von gefässeokklusion
UY27438A1 (es) Composición farmaceútica que comprende un conjugado oligómero-farmaco insulina, método para tratar deficiencia de insulina en un sujeto, método para proveer una composición farmacéutica.
DE602005018043D1 (de) Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung
DE602006016760D1 (de) Zusammensetzungen und verfahren zur kontrolle, prävention und behandlung von essstörungen
DE602005023877D1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
ATE325133T1 (de) Verfahren zur herstellung von fibrinogen und fibronectin sowie proteinzusammesetzungen, welche damit herstellbar sind
HK1086479A1 (en) The use of a ursodeoxycholic acid in the preparation of a medicament for treating a hemorrhage-associated nervous system injury
WO2008079270A3 (en) Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
ATE373014T1 (de) Einen nanofiltrationsschritt umfassendes verfahren zur aufreinigung von albumin, lösung und zusammensetzung zur therapeutischen anwendung,die dieses enthalten
ATE435026T1 (de) Verfahren zur prävention und behandlung von diabetes mit neurturin
ATE481101T1 (de) Verfahren zur behandlung von angstzuständen
BR0111158A (pt) Composto e sais fisiológicos do mesmo, método para tratar uma condição mediana por tnf-a em um paciente
ATE247947T1 (de) Verfahren und zusammensetzung zur behandlung von akne
DE602005020178D1 (de) 5,6,7-trihydroxyheptansäure und analoge zur behandlung von augenkrankheiten und mit hyperproliferativen und angiogenen reaktionen verbundenen krankheiten
ATE404577T1 (de) Verfahren zur herstellung von eplerenon
ATE343398T1 (de) Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
DE602004003173D1 (de) Verwendung von konjugierter Linolsäure zur Behandlung der Erkältung
ATE353886T1 (de) Verbindungen und verfahren zur behandlung einer hyperaktiven blase
ATE297211T1 (de) Verfahren und zusammensetzung zur behandlung von adenovirale augeninfektionen
ATE451367T1 (de) Verfahren zur herstellung von ziprasidon
BR0308753A (pt) Método para produzir pseudo-ilhotas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties